Electromed Business Summary

Electromed, Inc. (ELMD) is a medical technology company that generates revenue through the development, manufacture, and commercialization of High Frequency Chest Wall Oscillation (HFCWO) systems, primarily its flagship SmartVest® Airway Clearance System. The company operates through three primary business segments: direct homecare, which accounts for over 90% of total revenue, homecare distributors, and institutional hospital sales. Electromed utilizes a direct-to-patient and physician-referral model, supported by a specialized sales force and a high-margin recurring revenue stream from system sales and related accessories. In the competitive landscape, Electromed contends with larger diversified medical device firms including Baxter International (via Hillrom’s The Vest), Philips (via RespirTech’s InCourage), and Tactile Medical (AffloVest). Despite the presence of these multi-billion dollar rivals, Electromed maintains a strong niche position as a pure-play leader in the bronchiectasis market, leveraging a high gross margin of approximately 78% and a targeted "Triple Down on Bronchiectasis" commercial strategy. Founded in 1992 by Robert D. Hansen and Craig N. Hansen, the company is currently led by President and CEO Jim Cunniff, who joined in 2023 with over 30 years of MedTech experience, including executive roles at Stryker Corporation and Kinetic Concepts. Supporting him is CFO Brad Nagel, a former divisional CFO at Medtronic with extensive expertise in global lung health and strategic planning. The leadership team is overseen by Board Chair Kathleen Skarvan, the company’s former CEO who is credited with driving its modern growth inflection. Notable institutional investors include Vanguard Group, BlackRock, and Acadian Asset Management, which collectively contribute to an institutional ownership stake of approximately 62%. The board also features seasoned industry veterans such as Stan Erickson and Kathleen Tune, providing deep expertise in healthcare venture capital and medical device commercialization.